NASDAQ:EYEN
Eyenovia Inc. Stock News
$0.750
-0.0710 (-8.65%)
At Close: May 17, 2024
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2019 Financial Results
12:30pm, Wednesday, 11'th Mar 2020
NEW YORK, March 11, 2020 -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its.
Safe Harbor Marinas buys two more marinas on Chesapeake Bay
02:29pm, Tuesday, 10'th Mar 2020
One of your neighbors posted in Neighbor News. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
Eyenovia to Participate in Two Upcoming Investor Conferences
01:30pm, Wednesday, 04'th Mar 2020
NEW YORK, March 04, 2020 -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its.
How Does Eyenovia, Inc. (NASDAQ:EYEN) Affect Your Portfolio Volatility?
12:33pm, Monday, 17'th Feb 2020
If you own shares in Eyenovia, Inc. (NASDAQ:EYEN) then it's worth thinking about how it contributes to the volatility...
Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?
02:25pm, Monday, 10'th Feb 2020
Zoetis Inc. (ZTS) will provide financial numbers for fourth-quarter 2019 and pipeline updates on Feb 13.
Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?
02:25pm, Monday, 10'th Feb 2020
Zoetis Inc. (ZTS) will provide financial numbers for fourth-quarter 2019 and pipeline updates on Feb 13.
Bluebird up 2% premarket on two new bullish calls
01:34pm, Monday, 03'rd Feb 2020
Bluebird bio (NASDAQ:BLUE) initiated with Buy rating and $120 (56% upside) price target at Bank of America. Upgraded to Outperform with a $100 price target at Evercore ISI. Shares up 2% premarket.Ce
Have Insiders Been Buying Eyenovia, Inc. (NASDAQ:EYEN) Shares?
02:55pm, Thursday, 19'th Dec 2019
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
Eyenovia Expands Scientific Advisory Board with Two Experts in Optometry
01:30pm, Thursday, 19'th Dec 2019
Eyenovia, Inc. (EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced tha
Eyenovia, Inc. (EYEN) Shares March Higher, Can It Continue?
02:02pm, Monday, 02'nd Dec 2019
As of late, it has definitely been a great time to be an investor Eyenovia, Inc. (EYEN).
All You Need to Know About Eyenovia, Inc. (EYEN) Rating Upgrade to Strong Buy
02:00pm, Wednesday, 27'th Nov 2019
Eyenovia, Inc. (EYEN) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Eyenovia Reports Third Quarter 2019 Financial Results
09:05pm, Wednesday, 13'th Nov 2019
NEW YORK, Nov. 13, 2019 -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its.
Can European Buyouts Aid Canopy Growth's (CGC) Q2 Earnings?
03:42pm, Tuesday, 12'th Nov 2019
Canopy Growth (CGC) acquires a number of European companies to expand its production base across a region that promises great opportunities.
